Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-22

Clinical Trial Update: Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Alzer and Diamel to prevent severe diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alzer
  • Diamel

Snippet

Sponsor: Catalysis SL | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED